Analysis of force developed by a AAA ATPase
Analysis of force developed by a AAA ATPase
批准号:
8334589
负责人:
SANFORD M SIMON
金额:
$30.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2015-08-31
关键词:
ATP HydrolysisATP phosphohydrolaseAddressAffectAmino AcidsApoptosisBacteriaBindingBiogenesisBiological ClocksBiologyCell CycleCell divisionCell physiologyClinical TreatmentClinical TrialsCommitDecision TreesDevicesDigestionFailureFamilyGene Expression RegulationGenerationsGenetic TranscriptionGoalsHalf-LifeHandHealthHumanIndividualLengthMalignant NeoplasmsMeasurementMeasuresMethodsMitochondriaModelingMolecular MachinesMovementMultiple MyelomaMultivesicular BodyMutateNervous System TraumaOutcomePathologyPerformancePropertyProteasome InhibitorProteinsProteolysisRecurrenceRegulationRoleSideSignal Transduction PathwaySiteStatistical DistributionsStressSurfaceSystemTechniquesTestingTherapeutic InterventionTimeTransport Protein GeneWarWorkantigen processingdesensitizationhuman diseaseinsightmembermulticatalytic endopeptidase complexpolypeptideprotein degradationreceptorsingle molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. This project will focus on studying the activity of these machines at the single molecule level. The model protein will be ClpX - it is the part of the proteosome, a key effect of protein degradation that unfolds the proteins to prepare them for degradation. . Cellular proteins differ widely in their liability, from half-lives of minutes to days. Regulated degradation, by allowing rapid changes in the levels of cellular proteins, helps control signal transduction pathways, the cell- cycle, transcription, apoptosis, antigen processing, biological clock control, differentiation and surface receptor desensitization. The questions to be addressed are: How is work partitioned between alternative outcomes? What is the maximum work that can be performed by the system? What factors limit its efficiency in performing work? These questions have health implications: human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies. Thus, understanding the regulation of the half-life of proteins should provide critical insights into cell physiology and pathology. The mishandling of aberrant proteins incurs penalties throughout biology: the survival of bacteria subjected to stress depends on the effective performance of systems which deal with misfolded and structurally aberrant proteins- to either fold them properly or destroy them. The specific questions to be addressed are: How hard can the device pull to cause unfolding? How many pulls are needed to commit irreversibly? What is the limit of pulling power, and the statistical distribution of pulling power? Answers to these questions will begin to reveal not just what these machines do but the decision tree that describes how outcomes are controlled and when machine capacity may be exceeded. We want to know not just how the machine works, but how its decision tree yields alternative outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the oncoprotein that drives FLC
-
批准号:10902751
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2023
-
负责人:SANFORD M SIMON
-
依托单位:
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
-
批准号:10826323
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2023
-
负责人:SANFORD M SIMON
-
依托单位:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
-
批准号:10652432
-
项目类别:
-
资助金额:$41.58万
-
财政年份:2020
-
负责人:SANFORD M SIMON
-
依托单位:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
-
批准号:10171814
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2020
-
负责人:SANFORD M SIMON
-
依托单位:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
-
批准号:10412971
-
项目类别:
-
资助金额:$41.58万
-
财政年份:2020
-
负责人:SANFORD M SIMON
-
依托单位:
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
-
批准号:10221308
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2019
-
负责人:SANFORD M SIMON
-
依托单位:
Single virions to study assembly of HIV-1
-
批准号:9270040
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2016
-
负责人:SANFORD M SIMON
-
依托单位:
Cellular Pathogenesis of Fibrolamellar Hepatocellular Carcinoma
-
批准号:9158744
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2016
-
负责人:SANFORD M SIMON
-
依托单位:
Single virions to study assembly of HIV-1
-
批准号:9459948
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2016
-
负责人:SANFORD M SIMON
-
依托单位:
The Center for HIV RNA Studies (CRNA)
-
批准号:8512871
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2012
-
负责人:SANFORD M SIMON
-
依托单位:
Analysis of force developed by a AAA ATPase
-
批准号:8536863
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2011
-
负责人:SANFORD M SIMON
-
依托单位:
Analysis of force developed by a AAA ATPase
-
批准号:8729491
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2011
-
负责人:SANFORD M SIMON
-
依托单位:
Analysis of force developed by a AAA ATPase
-
批准号:8206159
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2011
-
负责人:SANFORD M SIMON
-
依托单位:
Biogenesis of HIV 1 in living cells
-
批准号:8288783
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2010
-
负责人:SANFORD M SIMON
-
依托单位:
Biogenesis of HIV 1 in living cells
-
批准号:8479309
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2010
-
负责人:SANFORD M SIMON
-
依托单位:
Selective fluorescent labeling of proteins in living cells
-
批准号:8000298
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2010
-
负责人:SANFORD M SIMON
-
依托单位:
Biogenesis of HIV 1 in living cells
-
批准号:8111266
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2010
-
负责人:SANFORD M SIMON
-
依托单位:
Biogenesis of HIV 1 in living cells
-
批准号:8016534
-
项目类别:
-
资助金额:$39.18万
-
财政年份:2010
-
负责人:SANFORD M SIMON
-
依托单位:
Selective fluorescent labeling of proteins in living cells
-
批准号:8280348
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2009
-
负责人:SANFORD M SIMON
-
依托单位:
Selective fluorescent labeling of proteins in living cells
-
批准号:8075098
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2009
-
负责人:SANFORD M SIMON
-
依托单位: